Dr Laurence Albiges discusses the management of papillary renal cell carcinoma (pRCC)

At the Thirteenth International Kidney Cancer Symposium, Dr Laurence Albiges (Gustave Roussy, France) provides an overview of papillary renal cell carcinoma (pRCC) and management options for these patients. pRCC comprises 1015% of renal cell carcinoma and specific therapies are not available. There are two clinically distinct types of pRCC. The more common Type 1 pRCC is associated with a mutation in the MET gene.